• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解读肺动脉高压中神秘的雌激素悖论:深入探究雌激素代谢产物和代谢酶

Decoding the enigmatic estrogen paradox in pulmonary hypertension: delving into estrogen metabolites and metabolic enzymes.

作者信息

You Qiang, Song Hequn, Zhu Ziming, Wang Jinzheng, Wang Ruixin, Du Mingjia, Fu Yingjie, Yuan Jinxiang, Tan Rubin

机构信息

Department of Physiology, Basic Medical School, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.

School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, Shandong, China.

出版信息

Cell Mol Biol Lett. 2024 Dec 18;29(1):155. doi: 10.1186/s11658-024-00671-w.

DOI:10.1186/s11658-024-00671-w
PMID:39695964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11653592/
Abstract

Pulmonary hypertension (PH) presents a puzzling sex bias, being more prevalent in women yet often less severe than in men, and the underlying reasons remain unclear. Studies using animal models, and limited clinical data have revealed a protective influence of exogenous estrogens, known as the estrogen paradox. Research suggests that beyond its receptor-mediated effects, estrogen acts through metabolites such as 2-ME2, 4-OHE2, and 16-OHE2, which are capable of exhibiting protective or detrimental effects in PH, prompting the need to explore their roles in PH to untangle sex differences and the estrogen paradox. Hypoxia disrupts the balance of estrogen metabolites by affecting the enzymes responsible for estrogen metabolism. Delving into the role of these metabolic enzymes not only illuminates the sex difference in PH but also provides a potential rationale for the estrogen paradox. This review delves into the intricate interplay between estrogen metabolites, metabolic enzymes, and PH, offering a deeper understanding of sex-specific differences and the perplexing estrogen paradox in the context of this condition.

摘要

肺动脉高压(PH)存在一种令人费解的性别偏见,在女性中更为普遍,但通常比男性病情较轻,其根本原因尚不清楚。使用动物模型的研究以及有限的临床数据揭示了外源性雌激素的保护作用,即所谓的雌激素悖论。研究表明,除了其受体介导的作用外,雌激素还通过2-ME2、4-OHE2和16-OHE2等代谢产物发挥作用,这些代谢产物在PH中可能表现出保护或有害作用,这促使人们需要探索它们在PH中的作用,以理清性别差异和雌激素悖论。缺氧通过影响负责雌激素代谢的酶来破坏雌激素代谢产物的平衡。深入研究这些代谢酶的作用不仅可以阐明PH中的性别差异,还为雌激素悖论提供了潜在的理论依据。本综述深入探讨了雌激素代谢产物、代谢酶和PH之间的复杂相互作用,以便在这种情况下更深入地理解性别特异性差异和令人困惑的雌激素悖论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2158/11653592/afac73b50970/11658_2024_671_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2158/11653592/f7e066d42eaf/11658_2024_671_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2158/11653592/e71f65c36ed5/11658_2024_671_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2158/11653592/c6c6682dee45/11658_2024_671_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2158/11653592/72663d0d887c/11658_2024_671_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2158/11653592/afac73b50970/11658_2024_671_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2158/11653592/f7e066d42eaf/11658_2024_671_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2158/11653592/e71f65c36ed5/11658_2024_671_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2158/11653592/c6c6682dee45/11658_2024_671_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2158/11653592/72663d0d887c/11658_2024_671_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2158/11653592/afac73b50970/11658_2024_671_Fig5_HTML.jpg

相似文献

1
Decoding the enigmatic estrogen paradox in pulmonary hypertension: delving into estrogen metabolites and metabolic enzymes.解读肺动脉高压中神秘的雌激素悖论:深入探究雌激素代谢产物和代谢酶
Cell Mol Biol Lett. 2024 Dec 18;29(1):155. doi: 10.1186/s11658-024-00671-w.
2
Progress in solving the sex hormone paradox in pulmonary hypertension.肺动脉高压中性激素悖论的研究进展。
Am J Physiol Lung Cell Mol Physiol. 2014 Jul 1;307(1):L7-26. doi: 10.1152/ajplung.00337.2013. Epub 2014 May 9.
3
Estrogen paradox in pulmonary hypertension: current controversies and future perspectives.肺动脉高压中的雌激素悖论:当前的争议和未来的展望。
Am J Respir Crit Care Med. 2012 Jul 15;186(2):125-31. doi: 10.1164/rccm.201201-0058PP. Epub 2012 May 3.
4
Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.雌激素与肺动脉高压的发生:雌二醇代谢与肺血管疾病的相互作用。
J Cardiovasc Pharmacol. 2010 Dec;56(6):696-708. doi: 10.1097/FJC.0b013e3181f9ea8d.
5
Sex-dependent influence of endogenous estrogen in pulmonary hypertension.内源性雌激素在肺动脉高压中的性别依赖性影响。
Am J Respir Crit Care Med. 2014 Aug 15;190(4):456-67. doi: 10.1164/rccm.201403-0483OC.
6
Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.肺动脉高压与右心衰竭中的性别、性别差异和性激素。
Compr Physiol. 2019 Dec 18;10(1):125-170. doi: 10.1002/cphy.c190011.
7
Role of the Aryl Hydrocarbon Receptor/ARNT/Cytochrome P450 System in Pulmonary Vascular Diseases.芳香烃受体/芳香烃受体核转位蛋白/细胞色素 P450 系统在肺血管疾病中的作用。
Circ Res. 2019 Jul 19;125(3):356-366. doi: 10.1161/CIRCRESAHA.119.315054. Epub 2019 Jun 26.
8
Pulmonary arterial hypertension: Sex matters.肺动脉高压:性别很重要。
Br J Pharmacol. 2024 Apr;181(7):938-966. doi: 10.1111/bph.16277. Epub 2024 Jan 16.
9
Estrogen Preserves Pulsatile Pulmonary Arterial Hemodynamics in Pulmonary Arterial Hypertension.雌激素可维持肺动脉高压患者的肺动脉搏动性血流动力学。
Ann Biomed Eng. 2017 Mar;45(3):632-643. doi: 10.1007/s10439-016-1716-1. Epub 2016 Aug 24.
10
Understanding the estrogen paradox of pulmonary arterial hypertension in the context of right ventricular function.在右心室功能背景下理解肺动脉高压的雌激素悖论。
Am J Physiol Heart Circ Physiol. 2024 Aug 1;327(2):H349-H350. doi: 10.1152/ajpheart.00400.2024. Epub 2024 Jun 21.

引用本文的文献

1
Signaling pathways and targeted therapy for pulmonary hypertension.肺动脉高压的信号通路与靶向治疗
Signal Transduct Target Ther. 2025 Jul 1;10(1):207. doi: 10.1038/s41392-025-02287-8.
2
LONP1 facilitates pulmonary artery smooth muscle cell glycolytic reprogramming by degrading MPC1 in pulmonary hypertension.LONP1通过降解肺动脉高压中的MPC1促进肺动脉平滑肌细胞糖酵解重编程。
Clin Sci (Lond). 2025 May 20;139(10):CS20255922. doi: 10.1042/CS20255922.

本文引用的文献

1
Clinical Response to Pulmonary Arterial Hypertension Treatment Does Not Depend on Pulmonary Arterial Wedge Pressure: A Meta-Analysis Using Individual Participant Data from Randomized Clinical Trials.肺动脉高压治疗的临床反应不取决于肺动脉楔压:一项使用随机临床试验个体参与者数据的荟萃分析
Am J Respir Crit Care Med. 2024 Sep 15;210(6):844-847. doi: 10.1164/rccm.202403-0612RL.
2
Mechanistic investigation of wogonin in delaying the progression of endothelial mesenchymal transition by targeting the TGF-β1 pathway in pulmonary hypertension.探讨白杨素通过靶向转化生长因子-β1 通路延缓肺动脉高压内皮间质转化的机制。
Eur J Pharmacol. 2024 Sep 5;978:176786. doi: 10.1016/j.ejphar.2024.176786. Epub 2024 Jun 27.
3
Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled Trial.
肺动脉高压和阿那曲唑(PHANTOM):一项随机、双盲、安慰剂对照试验。
Am J Respir Crit Care Med. 2024 Nov 1;210(9):1143-1151. doi: 10.1164/rccm.202402-0371OC.
4
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets.缺血再灌注损伤:分子机制与治疗靶点。
Signal Transduct Target Ther. 2024 Jan 8;9(1):12. doi: 10.1038/s41392-023-01688-x.
5
Pulmonary hypertension.肺动脉高压
Nat Rev Dis Primers. 2024 Jan 4;10(1):1. doi: 10.1038/s41572-023-00486-7.
6
Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension.FOXF1 减少与肺动脉高压相关的未修复 DNA 损伤。
Nat Commun. 2023 Nov 21;14(1):7578. doi: 10.1038/s41467-023-43039-y.
7
Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1.肺动脉高压患者和对照者的肺血管细胞对 TNFα 的反应差异及 BET 抑制剂 JQ1 的作用。
Respir Res. 2023 Jul 29;24(1):193. doi: 10.1186/s12931-023-02499-y.
8
Metabolic reprogramming, oxidative stress, and pulmonary hypertension.代谢重编程、氧化应激与肺动脉高压。
Redox Biol. 2023 Aug;64:102797. doi: 10.1016/j.redox.2023.102797. Epub 2023 Jun 24.
9
17β-hydroxysteroid dehydrogenases in the progression of nonalcoholic fatty liver disease.17β-羟甾类脱氢酶在非酒精性脂肪性肝病进展中的作用。
Pharmacol Ther. 2023 Jun;246:108428. doi: 10.1016/j.pharmthera.2023.108428. Epub 2023 Apr 26.
10
YuPingFengSan ameliorates LPS-induced acute lung injury and gut barrier dysfunction in mice.鱼腥风散可改善 LPS 诱导的小鼠急性肺损伤和肠道屏障功能障碍。
J Ethnopharmacol. 2023 Aug 10;312:116452. doi: 10.1016/j.jep.2023.116452. Epub 2023 Apr 3.